Abstract

Di-(2-ethylhexyl) phthalate (DEHP) is an endocrine disrupting chemical commonly used as a plasticizer in medical equipment, food packaging, flooring, and children’s toys. DEHP exposure during early development has been associated with adverse neurobehavioral outcomes in children. In animal models, early exposure to DEHP results in abnormal development of the reproductive system as well as altered behavior and neurodevelopment. Based on these data, we hypothesized that developmental exposure to DEHP would decrease social interactions and increase anxiety-like behaviors in mice in a dose-dependent manner, and that the effects would persist over generations. C57BL/6J mice consumed one of three DEHP doses (0, 5, 40, and 400 μg/kg body weight) throughout pregnancy and during the first ten days of lactation. The two higher doses yielded detectable levels of DEHP metabolites in serum. Pairs of mice from control, low, and high DEHP doses were bred to create three dose lineages in the third generation (F3). Average anogenital index (AGI: anogenital distance/body weight) was decreased in F1 males exposed to the low dose of DEHP and in F1 females exposed to the highest dose. In F1 mice, juvenile pairs from the two highest DEHP dose groups displayed fewer socially investigative behaviors and more exploratory behaviors as compared with control mice. The effect of DEHP on these behaviors was reversed in F3 mice as compared with F1 mice. F1 mice exposed to low and medium DEHP doses spent more time in the closed arms of the elevated plus maze than controls, indicating increased anxiety-like behavior. The generation-dependent effects on behavior and AGI suggest complex mechanisms by which DEHP directly impacts reproductive and neurobehavioral development and influences germline-inherited traits.

Highlights

  • Di-(2-ethylhexyl) phthalate (DEHP) is a synthesized component of flexible plastics used to make polyvinyl chloride (PVC), some types of packaging, medical tubing, synthetic flooring and other products [1,2,3]

  • We evaluated three low doses of DEHP: 5, 40, and 400 μg/kg, all of which are below the no observed effect level (NOAEL, 4.8 mg/kg/day) for DEHP and comparable to normal human intake [37]

  • Two of the three serum samples from dams dosed at 40 μg/kg had detectable mono-(2-ethylhexyl) phthalate (MEHP) levels and one had detectable 5-OH-MEHP levels (0.54 ng/ml)

Read more

Summary

Introduction

Di-(2-ethylhexyl) phthalate (DEHP) is a synthesized component of flexible plastics used to make polyvinyl chloride (PVC), some types of packaging, medical tubing, synthetic flooring and other products [1,2,3]. Concentrations of DEHP in manufactured materials may reach 40% by weight and over 98% of the US population has detectable levels of its metabolites in urine [4]. This endocrine disrupting chemical (EDC) crosses the placenta [5], is absorbed through the skin [6], and its metabolites are found in human breast milk [7]. Increased gestational DEHP levels correlate with decreased AGD in male rodents [14,15,16] and humans [17,18,19], which further indicates its anti-androgenic actions

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call